Liver resections in metastatic gastric cancer.

ABSTRACT:

Background

The 5-year survival of patients receiving standard-of-care chemotherapy for metastatic gastric cancer (MGC) to the liver is <2%. This review examines the published data on liver resections for MGC and analyses the rationale for potentially aggressive surgical management.

Methods

A search of the PubMed and Scopus databases was used to identify studies published in English from 1990 to 2009 that reported on 10 or more patients who underwent liver resections for MGC. All available clinicopathologic data were analysed. In particular, we examined longterm survival and the characteristics of individuals surviving for >5 years.

Results

Nineteen studies reported on 436 patients. Median 5-year survival was 26.5% (range: 0-60%). Overall, 13.4% (48/358) of patients we

SUBMITTER: Kerkar SP 

PROVIDER: S-EPMC2999785 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature